Ophthalmology and Visual Sciences Archives
Nov. 12, 2015—David Morrison, M.D., associate professor of Ophthalmology and Pediatrics at Vanderbilt, is the new president of the American Orthoptic Council (AOC). He will serve a two-year term.
Daniels receives research grant from Knights Templar Eye Foundation to study retinoblastoma treatment
Jun. 25, 2015—Vanderbilt investigator Anthony Daniels has received a grant from the Knights Templar Eye Foundation to develop new, safe and effective treatments for retinoblastoma, the most common ocular cancer in children.
Jun. 25, 2015—The Vanderbilt Eye Institute recently received a grant for $115,000 from Research to Prevent Blindness, placing the total award amount for unrestricted grants from the organization at $860,000.
Beware the eyes of March: Vanderbilt ophthalmologist offers tips for preventing and treating dry eyes during windy weather
Mar. 23, 2015—For the past few months, much of the nation has donned hats, boots, scarves and gloves as they face brutally cold and icy conditions of winter. As temperatures rise, making outdoor activities more enticing, Vanderbilt ophthalmologists suggest not to be in such a hurry to stop protecting yourself from the elements. Why? March is known...
Oct. 16, 2014—It’s been 20 years since Project PAVE, a Tennessee program providing low-vision evaluations for children, was launched.
Oct. 9, 2014—Conventional therapy for patients diagnosed with retinoblastoma, the most common ocular cancer in children, includes systemic chemotherapy, external beam radiation and/or surgical removal of the eye. Doctors at Vanderbilt University Medical Center are on track to radically change the way the disease is treated using an emerging therapeutic approach called intra-arterial chemotherapy, or IA chemo.
Oct. 2, 2014—Vanderbilt University has launched a regenerative visual neuroscience initiative to develop new ways of treating — and restoring sight to — people who have been blinded by glaucoma, macular degeneration, diabetic retinopathy and eye injuries.